Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1316998 | Journal of Inorganic Biochemistry | 2011 | 7 Pages |
Five oxaliplatin-typed platinum complexes containing trans-1R, 2R-diaminocyclohexane chelating platinum cores, characteristic of linear or branched alkoxycarboxylates as leaving groups, were biologically evaluated. These compounds showed higher antitumor activity, lower toxicity in vivo than cisplatin or oxaliplatin. And the results revealed that the antitumor activity and interaction with DNA of these compounds were highly related to the nature of leaving groups. Among these complexes, 5a, cis-(trans-1R, 2R-diaminocyclohexane) bis (2-tert-butoxyacetate) platinum(II), showed the highest antitumor activity and the lowest toxicity.
Graphical abstractIn vivo antitumor activity and toxicity of novel designed platinum complexes were highly related to the nature of leaving groupsFigure optionsDownload full-size imageDownload as PowerPoint slide